Key details about broadly neutralizing antibodies provide insights for universal flu vaccine
New research on polyreactive broadly neutralizing antibodies shows the challenges of balancing an effective immune response.
South Side resident takes part in rare sickle cell disease clinical trial through UChicago Medicine
After managing sickle cell disease (SCD) throughout her life, Lyric Porter became the first patient in Illinois — and the third in the world — to participate in an SCD gene therapy clinical trial at UChicago Medicine Comer Children’s Hospital.
New findings show private equity investments in healthcare may not lower costs or improve quality of care
A research team supervised by a health policy researcher at the University of Chicago has found that increasingly common private equity investments in healthcare are generally associated with higher costs to patients and payers.
